We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Mosaic (MOS) to Report Q4 Earnings: What's in the Offing?
Read MoreHide Full Article
The Mosaic Company (MOS - Free Report) is set to release fourth-quarter 2019 results after the closing bell on Feb 19. The impacts of lower prices and sales volumes are likely to reflect on its results. Hefty charges are also expected to have impacted its margins in the quarter.
Mosaic’s adjusted earnings of 8 cents per share for the third quarter fell well short of the Zacks Consensus Estimate of 27 cents, translating into a negative surprise of around 70.4%. The company faced challenging market conditions in the quarter.
The fertilizer maker beat the Zacks Consensus Estimate for earnings in two of the trailing four quarters while missed twice. In this timeframe, it delivered a negative surprise of around 19.1%, on an average.
Mosaic’s shares are down 41.6% over a year compared with the industry’s 20.6% fall.
Let’s see how things are shaping up for this announcement.
What do the Estimates Indicate?
The Zacks Consensus Estimate for Mosaic’s fourth-quarter consolidated sales is currently pegged at $1,941 million, which suggests a fall of 23% from the year-ago quarter’s tally.
The Zacks Consensus Estimate for net sales for the Phosphates segment is currently pegged at $774 million, indicating a decline of 16.4% year over year.
Moreover, the consensus mark for net sales for the Potash segment currently stands at $430 million, which calls for an expected decline of 27.4% year over year.
The Zacks Consensus Estimate for net sales for the Mosaic Fertilizantes segment is currently pegged at $804 million, which reflects an expected decline of 17% year over year.
Some Factors at Play
The company’s fourth-quarter results are expected to reflect the impacts of weaker selling prices and sales volumes. Mosaic, in December, said that the third consecutive disappointing fertilizer application season in North America resulted in continued price weakness and high inventories. These conditions have affected both phosphates and potash. The company also stated that it intends to reduce fertilizer production until markets improve.
Mosaic, last month, also noted that the average realized price of phosphate continued to decline in the fourth quarter, affecting the annual goodwill impairment analysis and leading the company to impair the Phosphates segment’s goodwill. It will record a Phosphates goodwill impairment charge of up to $590 million in the fourth quarter.
Moreover, the company also announced plans to keep the Colonsay potash mine in Saskatchewan, Canada, idled for the foreseeable future due to soft demand conditions. The mine will be positioned in the care and maintenance phase, employ limited staff and allow operations to be resumed when necessary to meet the needs of customers. The company said that it will record pretax charges of around $530 million in the fourth quarter associated with the idling.
As such, these sizable charges related to the goodwill impairment and idling are likely to have weighed on the company’s bottom line in the December quarter.
Lower phosphate prices are also likely to have hurt sales and margins in the Phosphates segment in the quarter to be reported. Prices remain under pressure amid an oversupply in the market and weak demand in North America. Soft market conditions are also likely to have hurt phosphate and potash sales volumes in the fourth quarter.
Our proven model does not predict an earnings beat for Mosaic this season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. But that’s not the case here.
Earnings ESP: Earnings ESP for Mosaic is +100.00%. The Zacks Consensus Estimate for the fourth quarter is currently pegged at a loss of a penny per share. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zacks Rank: Mosaic carries a Zacks Rank #5.
Stocks That Warrant a Look
Here are some companies in the basic materials space you may want to consider as our model shows they have the right combination of elements to post an earnings beat this quarter:
AK Steel Holding Corporation , scheduled to release earnings on Feb 20, has an Earnings ESP of +11.11% and carries a Zacks Rank #3.
First Majestic Silver Corp. (AG - Free Report) , slated to release earnings on Feb 19, has an Earnings ESP of +8.33% and carries a Zacks Rank #3.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
Mosaic (MOS) to Report Q4 Earnings: What's in the Offing?
The Mosaic Company (MOS - Free Report) is set to release fourth-quarter 2019 results after the closing bell on Feb 19. The impacts of lower prices and sales volumes are likely to reflect on its results. Hefty charges are also expected to have impacted its margins in the quarter.
Mosaic’s adjusted earnings of 8 cents per share for the third quarter fell well short of the Zacks Consensus Estimate of 27 cents, translating into a negative surprise of around 70.4%. The company faced challenging market conditions in the quarter.
The fertilizer maker beat the Zacks Consensus Estimate for earnings in two of the trailing four quarters while missed twice. In this timeframe, it delivered a negative surprise of around 19.1%, on an average.
Mosaic’s shares are down 41.6% over a year compared with the industry’s 20.6% fall.
Let’s see how things are shaping up for this announcement.
What do the Estimates Indicate?
The Zacks Consensus Estimate for Mosaic’s fourth-quarter consolidated sales is currently pegged at $1,941 million, which suggests a fall of 23% from the year-ago quarter’s tally.
The Zacks Consensus Estimate for net sales for the Phosphates segment is currently pegged at $774 million, indicating a decline of 16.4% year over year.
Moreover, the consensus mark for net sales for the Potash segment currently stands at $430 million, which calls for an expected decline of 27.4% year over year.
The Zacks Consensus Estimate for net sales for the Mosaic Fertilizantes segment is currently pegged at $804 million, which reflects an expected decline of 17% year over year.
Some Factors at Play
The company’s fourth-quarter results are expected to reflect the impacts of weaker selling prices and sales volumes. Mosaic, in December, said that the third consecutive disappointing fertilizer application season in North America resulted in continued price weakness and high inventories. These conditions have affected both phosphates and potash. The company also stated that it intends to reduce fertilizer production until markets improve.
Mosaic, last month, also noted that the average realized price of phosphate continued to decline in the fourth quarter, affecting the annual goodwill impairment analysis and leading the company to impair the Phosphates segment’s goodwill. It will record a Phosphates goodwill impairment charge of up to $590 million in the fourth quarter.
Moreover, the company also announced plans to keep the Colonsay potash mine in Saskatchewan, Canada, idled for the foreseeable future due to soft demand conditions. The mine will be positioned in the care and maintenance phase, employ limited staff and allow operations to be resumed when necessary to meet the needs of customers. The company said that it will record pretax charges of around $530 million in the fourth quarter associated with the idling.
As such, these sizable charges related to the goodwill impairment and idling are likely to have weighed on the company’s bottom line in the December quarter.
Lower phosphate prices are also likely to have hurt sales and margins in the Phosphates segment in the quarter to be reported. Prices remain under pressure amid an oversupply in the market and weak demand in North America. Soft market conditions are also likely to have hurt phosphate and potash sales volumes in the fourth quarter.
The Mosaic Company Price and EPS Surprise
The Mosaic Company price-eps-surprise | The Mosaic Company Quote
Zacks Model
Our proven model does not predict an earnings beat for Mosaic this season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. But that’s not the case here.
Earnings ESP: Earnings ESP for Mosaic is +100.00%. The Zacks Consensus Estimate for the fourth quarter is currently pegged at a loss of a penny per share. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zacks Rank: Mosaic carries a Zacks Rank #5.
Stocks That Warrant a Look
Here are some companies in the basic materials space you may want to consider as our model shows they have the right combination of elements to post an earnings beat this quarter:
Eldorado Gold Corporation (EGO - Free Report) , scheduled to release earnings on Feb 20, has an Earnings ESP of +23.81% and carries a Zacks Rank #3. You can see the complete list of today’s Zacks #1 Rank stocks here.
AK Steel Holding Corporation , scheduled to release earnings on Feb 20, has an Earnings ESP of +11.11% and carries a Zacks Rank #3.
First Majestic Silver Corp. (AG - Free Report) , slated to release earnings on Feb 19, has an Earnings ESP of +8.33% and carries a Zacks Rank #3.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>